Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Medicine, Pulmonary hypertension, Cardiology, Angiogenesis, Internal medicine, and Intensive care medicine.
Single-Cell and Spatial Transcriptomics Identified Fatty Acid–Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)
Infection and pulmonary vascular diseases consortium: United against a global health challenge
Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension
Seeing pulmonary hypertension through a paediatric lens: a viewpoint
Specialized Pericyte Subtypes in the Pulmonary Capillary
HIF2A Activation Reduces Pulmonary Angiogenesis and Promotes Vascular Remodeling in PAH by Suppressing Wnt7a Production in Pulmonary Endothelial Cells
Loss of ROR2 Tyrosine Kinase Receptor Is Associated With Dysfunctional Angiogenesis in PAH Via Inappropriate Focal Adhesion Activation and Disruption of the Endothelial Barrier
Hymecromone Improves Functional Performance in Individuals With Group 3 Pulmonary Hypertension
Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
Overexpression of Pericyte HIF2α Exacerbates Hypoxia Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
Abstract 9804: Overexpression of Pericyte Hif2a Exacerbates Hypoxia Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
Development and Testing of Walk Talk Track App - A Wearables-Based Platform for Mobile 6MWT Monitoring
Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension
Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension
Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension